Skip to content

Clinical study on traditional Chinese medicine for the treatment of gastric cancer with anemia

Clinical study on traditional Chinese medicine for the treatment of gastric cancer with anemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003604
Enrollment
Unknown
Registered
2013-07-22
Start date
2013-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

YZSX Capsule group:Yizhongshengxue Capsule + The basic treatment of Conventional medicine
treatment group1:Compound E-Jiao Slurry + The basic treatment of conventional medicine

Sponsors

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Have all of the following 7 criteria: 1. Conform to the diagnosis of gastric cancer and TNM stage III-IV; 2. Conform to the diagnostic criteria of anemia (mild or moderate anemia); 3. In accordance with the standards of syndrome differentiation on weakness of the spleen and stomach and deficiency of qi and blood; 4. Age between 18 and 75 years old; 5. Stop using erythropoietin, iron, folic acid, vitamin B12, sex hormones at least for a month before the study; 6. Exclude major bleeding such as hematemesis, hematochezia caused by blood vessels invaded by gastric cancer; 7. Volunteers, and signed the informed consent.

Exclusion criteria

Exclusion criteria: Have any one of the following: 1. Not meet the above inclusion criteria; 2. With heart, liver, kidney and other important organs functions damage; 3. Pregnant women and mental patients; 4. Unable to follow the prescription; 5. The patient is forced to interrupt treatment because of severe side effects during the treatment.

Design outcomes

Primary

MeasureTime frame
Red blood cell;Hemoglobin;Hematocrit;Mean corpuscular volume;Erythrocyte hemoglobin distribution width;Degree of anemia classification;Symptoms and signs;Quality of life;White blood cell;

Secondary

MeasureTime frame
Platelet;Concertration of serum erythropoietin;Serum iron;Total iron binding capacity;Siderophilin;Serum ferritin;Serum vitamin B12;Serum folic acid;

Countries

China

Contacts

Public ContactXinyi Chen

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

chenxinyi0729@126.com+86 010 84013127

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026